Recursion Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.
Recursion Pharmaceuticals has raised $239M across 1 funding round on record, the most recent an undisclosed round of $239M announced in Sep 2020.
That round is above the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Recursion Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Recursion Pharmaceuticals Funding Rounds
Recursion Pharmaceuticals Founders and Leadership Team
Contact details for the Recursion Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Recursion Pharmaceuticals Funding Compared to Other Artificial Intelligence Startups
Recursion Pharmaceuticals' latest round of $239M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Recursion Pharmaceuticals in Artificial Intelligence and Salt Lake City
Companies Similar to Recursion Pharmaceuticals
Sirona Medical Inc. is addressing the needs of today’s radiology practices with a novel cloud-native platform…
Leading health plans, program providers, and over 100 communities across the U.S., rely on CredibleMind to…
RapidCanvas is an AI platform that combines the precision and automation of AI agents with the deep domain…
Labelbox is a collaborative data training platform that creates and manages labeled data for machine learning…
Clueso is an AI-driven support system for SaaS applications.
Dapta is a software-as-a-service company that provides a platform with minimal coding required to create APIs…
Factored was co-founded with renowned AI expert Andrew Ng (Stanford/AI Fund/Google Brain/Coursera) and…
Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor…
Lightsprint provides an AI-native product development platform that supports collaborative software…
Suki is a leading technology company that provides AI-powered voice solutions for healthcare. Its mission is…
Drylab is an AI-powered bioinformatics platform for biomedical data analysis, research workflows, and…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Recursion Pharmaceuticals Funding FAQs
What does Recursion Pharmaceuticals do?
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.
How much funding has Recursion Pharmaceuticals raised?
Recursion Pharmaceuticals has raised $239M across 1 round on record. The most recent is an undisclosed round of $239M announced in Sep 2020.
When did Recursion Pharmaceuticals last raise funding?
Recursion Pharmaceuticals' most recent funding round on record is an undisclosed round of $239M, announced in Sep 2020.
Who is the CEO of Recursion Pharmaceuticals?
Chris Gibson is listed as CEO at Recursion Pharmaceuticals.
Where is Recursion Pharmaceuticals headquartered?
Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.
How many employees does Recursion Pharmaceuticals have?
Recursion Pharmaceuticals is in the 101-250 employee band.
How does Recursion Pharmaceuticals' funding compare to other Artificial Intelligence startups?
Recursion Pharmaceuticals' latest round of $239M is above the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,243 tracked companies over the last two years.
About FundedIQ's Recursion Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Recursion Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.